← All 3m CO filings

3m CO 8-K filings

NYSE
MMM
3m CO
8-K: 3M Appoints William Brown as CEO, Michael Roman Transitions to Executive Chairman
3M has announced the appointment of William Brown as CEO, succeeding Michael Roman who will become Executive Chairman, both effective May 1, 2024.
NYSE
MMM
3m CO
8-K: 3M Board Approves Spin-Off of Health Care Business, Solventum, Set for April 1st
3M's board has approved the spin-off of its Health Care business, Solventum, with distribution of shares to 3M shareholders expected before trading on April 1, 2024.
NYSE
MMM
3m CO
8-K: Solventum Corporation Issues \$6.9 Billion in Senior Notes Ahead of Planned Spin-Off
Solventum Corporation, a subsidiary of 3M, has successfully issued \$6.9 billion in senior notes to finance its upcoming spin-off from 3M.
NYSE
MMM
3m CO
8-K: 3M Amends Combat Arms Earplug Settlement, Elects to Pay $1 Billion in Cash
3M has amended its settlement agreement regarding Combat Arms Earplugs litigation, choosing to pay $1 billion in cash instead of stock and revising payment timelines.
NYSE
MMM
3m CO
8-K: 3M Reports Strong Q4 Results, Exceeds Expectations and Provides 2024 Outlook
3M's fourth-quarter results exceeded expectations, driven by strong operational execution, restructuring progress, and spending discipline, with a positive outlook for 2024.
NYSE
MMM
3m CO
8-K: 3M Accelerates $253.1 Million Payment in Combat Arms Earplug Settlement as All Wave Plaintiffs Agree to Participate
3M has amended the timing of its Combat Arms Earplug settlement agreement, accelerating a $253.1 million payment to on or before January 31, 2024, following 100% participation from remaining wave plaintiffs.